Skip to main content

Table 1 Healthy control and patient characteristics

From: Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume

Demographical and
laboratory data
Healthy controls (n = 60) Type 2 diabetic patients (n = 60)
Female/Male sex (n) 28/32 28/32
Age, years (mean ± SD) 60.1 ± 3.5 60.8 ± 3.5
Platelet count, 109/L (mean ± SD) 210.5 ± 103.3 200.1 ± 83.7
P-Magnesium, mmol/L (mean ± SD) 0.85 ± 0.07 0.82 ± 0.08
P-Albumin, g/L (mean ± SD) 41.6 ± 2.9 41.0 ± 3.7
Therapy at admission (n)
  Insulin - 19
  Peroral antidiabetics - 37
  Acetylsalicylic acid (ASA) - 16
  Anticoagulants or Platelet inhibitor (other than ASA) - 2
  Anti-inflammatory drugs - 3
  ACE inhibitors - 16
  Angiotensin receptor blockers (ARB) - 5
  Beta blockers - 16
  Calcium antagonists - 7
  Diuretics - 14
  Statins - 29
  Selective serotonin reuptake inhibitors (SSRI) - 4
  Bensodiazepines - 1